Evidence map›Paper›PMID 32193329›Full record

ArticleScience (New York, N.Y.)2020

cFLIP

Hayley I Muendlein, David Jetton, Wilson M Connolly, Keith P Eidell, Zoie Magri, Irina Smirnova, Alexander Poltorak

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Review: the role of GSDMD in sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Pooled it
  2. Mechanisms, regulation and clinical relevance of necroptosis.Nature reviews. Molecular cell biology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Raver1 linksProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Hayley I MuendleinGraduate Program in Genetics, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.ORCID 0000-0003-3006-5780
David JettonGraduate Program in Immunology, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.ORCID 0000-0002-1615-9986
Wilson M ConnollyDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Keith P EidellGraduate Program in Immunology, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.
Zoie MagriGraduate Program in Immunology, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.ORCID 0000-0001-9378-4278
Irina SmirnovaDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Alexander PoltorakDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA. alexander.poltorak@tufts.edu.ORCID 0000-0002-5375-6587
Tufts University · US

Funding

Hyper-Responsiveness to TLR Agonists in Wild Derived MiceR01AI056234 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2003 to 2023
$8.4M
DNA-RESPONSES IN WILD-DERIVED MICER21AI135369 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2018 to 2019
$454k
Understanding the mechanism of host responses to pathogen-derived DNAR21AI145357 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2019 to 2020
$446k
Hyper-Responsiveness to TLR Agonists in Wild Derived MiceR56AI056234 · NIAID · TUFTS UNIVERSITY BOSTON · PI POLTORAK, ALEXANDER · 2008 to 2008
$411k
NIAID NIH HHS R01 AI056234NIAID NIH HHS R21 AI135369NIAID NIH HHS R21 AI145357NIAID NIH HHS R56 AI056234
6 · The paper itself

Abstract

Cell death and inflammation are interdependent host responses to infection. During pyroptotic cell death, interleukin-1β (IL-1β) release occurs through caspase-1 and caspase-11-mediated gasdermin D pore formation. In vivo, responses to lipopolysaccharide (LPS) result in IL-1β secretion. In vitro, however, murine macrophages require a second "danger signal" for the inflammasome-driven maturation of IL-1β. Recent reports have shown caspase-8-mediated pyroptosis in LPS-activated macrophages but have provided conflicting evidence regarding the release of IL-1β under these conditions. Here, to further characterize the mechanism of LPS-induced secretion in vitro, we reveal an important role for cellular FLICE-like inhibitory protein (cFLIP) in the regulation of the inflammatory response. Specifically, we show that deficiency of the long isoform cFLIP

Indexed as

Macrophage ActivationPyroptosisAnimalsCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 1Caspase 8Electron Transport Complex IIGene Knockdown TechniquesInflammasomesInterleukin-1betaLipopolysaccharidesMacrophagesMiceNLR Family, Pyrin Domain-Containing 3 ProteinCasp1 protein, mouseCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 1Caspase 8Cflar protein, mouseElectron Transport Complex IIIL1B protein, mouseInflammasomesInterleukin-1betaLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 Protein

Identifiers

PMID32193329
PMCPMC7375259
OpenAlexW3011994965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.